More tools:Markets·Screener·Research·Chat

CapsoVision, Inc. Common Stock (CV) Financial Statements

CapsoVision, Inc. Common Stock
SIC 3845 · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
FIGI BBG00KHZ9QK0
XNAS · usd
6.36▲ 0.37 (6.18%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value—
Trailing P/E—
Price / Sales
EV / Revenue—
EV / EBITDA—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt—
Trading Information
Previous Close5.99
Day's Range5.99 – 6.99
52-Week Range3.43 – 15.37
Volume391.1K
Avg Volume95.6K
Share Statistics
Shares Outstanding
Employees99
ExchangeXNAS
Listed2025-07-02
Share count as of August 12, 2026
Loading Income Statement…
Key questions about CapsoVision, Inc. Common Stock (CV)
What is CapsoVision, Inc. Common Stock's Market Cap?
CapsoVision, Inc. Common Stock's Market Cap is $318.3M, based on as-reported figures from SEC (XBRL) filings.
What is CapsoVision, Inc. Common Stock's Price / Sales?
CapsoVision, Inc. Common Stock's Price / Sales is 22.9×, based on as-reported figures from SEC (XBRL) filings.
What is CapsoVision, Inc. Common Stock's Revenue (TTM)?
CapsoVision, Inc. Common Stock's Revenue (TTM) is $13.9M, based on as-reported figures from SEC (XBRL) filings.
What is CapsoVision, Inc. Common Stock's Net Income (TTM)?
CapsoVision, Inc. Common Stock's Net Income (TTM) is -$29.8M, based on as-reported figures from SEC (XBRL) filings.
What is CapsoVision, Inc. Common Stock's EBITDA?
CapsoVision, Inc. Common Stock's EBITDA is -$29.9M, based on as-reported figures from SEC (XBRL) filings.
What is CapsoVision, Inc. Common Stock's Diluted EPS (TTM)?
CapsoVision, Inc. Common Stock's Diluted EPS (TTM) is -0.60, based on as-reported figures from SEC (XBRL) filings.
What is CapsoVision, Inc. Common Stock's EBITDA Margin?
CapsoVision, Inc. Common Stock's EBITDA Margin is -215.5%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Net revenue
YoY growth+9.9%+0.3%+13.5%+19.3%
Costs of revenue
Gross profit
% of revenue51.4%47.6%49.9%54.1%
Selling and marketing
Research and development
General and administrative
Total operating expenses
% of revenue259.4%301.6%240.4%280.8%
Operating loss
% of revenue-208.1%-254.0%-190.5%-226.7%
Interest income, net
Other non-operating income (expense), net
Total non-operating income, net
Loss before income taxes
Provision for income taxes
Net loss
% of revenue-205.4%-251.9%-188.7%-223.9%
Net loss per share - basic (in dollars per share)—
Net loss per share - diluted (in dollars per share)—